targeted therapy

2022 ASCO Annual Meeting; #ASCO22
June 5, 2022
Leslie Fannon Zhang, ASCO staff

2022 ASCO Annual Meeting: Advances in Treating Breast Cancer, Colorectal Cancer, Ewing Sarcoma, and Multiple Myeloma

English
Leslie.Fannon.Zhang

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include advances in treating HER2-low metastatic breast cancer, RAS wild-type metastatic colorectal cancer, recurrent and refractory Ewing sarcoma, and newly diagnosed multiple myeloma.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 4, 2022
Brielle Gregory Collins, ASCO staff

2022 ASCO Annual Meeting: Targeted Therapy for Advanced HR-Positive, HER2-Negative Breast Cancer and Using Liquid Biopsy to Guide Treatment for Stage II Colon Cancer

English
Brielle.Gregory.Collins

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Topics include targeted therapy for advanced hormone receptor-positive, HER2-negative breast cancer and using liquid biopsy to guide post-surgery treatment decisions for stage II colon cancer.

Read More >>
2022 ASCO Annual Meeting; #ASCO22
June 3, 2022
Greg Guthrie, ASCO staff

2022 ASCO Annual Meeting: Improving Standard Care for Advanced Pancreatic Cancer and Older Adults with Mantle Cell Lymphoma

English
gregguthrie

The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma.

Read More >>
February 3, 2022
Brielle Gregory Collins, ASCO staff

New Research in Treating Lymphoma and Improving Equity in Cancer Clinical Trials: ASH Annual Meeting 2021

English
Brielle.Gregory.Collins

In this podcast, Dr. Christopher Flowers discusses research from the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, including studies evaluating new treatments for diffuse large B-cell lymphoma and an overview of a session on improving equity in cancer clinical trials.

Read More >>

Pages

Subscribe to RSS - targeted therapy